Procurement of Specialized Oncology Pharmaceuticals for Indian Army Healthcare

Work Description - NA

This tender, originating from the Department of Military Affairs, Ministry of Defence, and issued by the Indian Army via Bid Number GEM/2026/B/7901305, seeks the supply of a comprehensive range of high-value pharmaceutical products. The bid is open for submission between 13-08-2026 at 1:56 PM and will close on 24-08-2026 at 2:00 PM. The scope of this procurement encompasses a significant total quantity of 52214 units, with the specific items including, but not limited to, Abiraterone 500mg tablets, Acalabrutinib 100mg capsules, Bicalutamide 50mg tablets, Crizotinib 250mg capsules, Dasatinib 50mg tablets, Eltrombopag 25mg tablets, Erlotinib in both 150mg and 100mg tablet forms, Gefitinib 250mg tablets, Imatinib Mesylate 100mg capsules, Denosumab 60mg injections, Lenalidomide in 10mg and 5mg tablet strengths, Lenvatinib in 4mg and 10mg tablet forms, Megestrol in 40mg and 160mg tablet strengths, Nintedanib in 150mg and 100mg tablet forms, Tamoxifen Citrate 20mg tablets, Anastrozole 1mg tablets, Hydroxyurea 500mg capsules, Letrozole 2.5mg tablets, Ribociclib 200mg tablets, and Nilotinib 200mg tablets. This critical requirement from the Indian Army necessitates prompt and efficient fulfillment to support military healthcare needs.